Copyright Reports & Markets. All rights reserved.

Global Albumin (as Excipient) Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Albumin (as Excipient) Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Albumin (as Excipient) Market Size Growth Rate by Type
    • 1.4.2 Human Serum Albumin
    • 1.4.3 Recombinant Albumin
  • 1.3 Market by Application
    • 1.3.1 Global Albumin (as Excipient) Market Size Growth Rate by Application
    • 1.3.2 Cell Culture Media
    • 1.3.3 Medical Supplements
    • 1.3.4 Therapeutics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Albumin (as Excipient) Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Albumin (as Excipient) Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Albumin (as Excipient) Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Albumin (as Excipient) Regions by Sales
    • 2.4.1 Global Top Albumin (as Excipient) Regions by Sales (2016-2021)
    • 2.4.2 Global Top Albumin (as Excipient) Regions by Sales (2022-2027)
  • 2.5 Global Top Albumin (as Excipient) Regions by Revenue
    • 2.5.1 Global Top Albumin (as Excipient) Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Albumin (as Excipient) Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Albumin (as Excipient) Sales by Manufacturers
    • 3.1.1 Global Top Albumin (as Excipient) Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Albumin (as Excipient) Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Albumin (as Excipient) Sales in 2020
  • 3.2 Global Albumin (as Excipient) Revenue by Manufacturers
    • 3.2.1 Global Top Albumin (as Excipient) Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Albumin (as Excipient) Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Albumin (as Excipient) Revenue in 2020
  • 3.3 Global Albumin (as Excipient) Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Albumin (as Excipient) Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Albumin (as Excipient) Sales by Type
    • 4.1.1 Global Albumin (as Excipient) Historical Sales by Type (2016-2021)
    • 4.1.2 Global Albumin (as Excipient) Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Albumin (as Excipient) Sales Market Share by Type (2016-2027)
  • 4.2 Global Albumin (as Excipient) Revenue by Type
    • 4.2.1 Global Albumin (as Excipient) Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Albumin (as Excipient) Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Albumin (as Excipient) Revenue Market Share by Type (2016-2027)
  • 4.3 Global Albumin (as Excipient) Price by Type
    • 4.3.1 Global Albumin (as Excipient) Price by Type (2016-2021)
    • 4.3.2 Global Albumin (as Excipient) Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Albumin (as Excipient) Sales by Application
    • 5.1.1 Global Albumin (as Excipient) Historical Sales by Application (2016-2021)
    • 5.1.2 Global Albumin (as Excipient) Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Albumin (as Excipient) Sales Market Share by Application (2016-2027)
  • 5.2 Global Albumin (as Excipient) Revenue by Application
    • 5.2.1 Global Albumin (as Excipient) Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Albumin (as Excipient) Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Albumin (as Excipient) Revenue Market Share by Application (2016-2027)
  • 5.3 Global Albumin (as Excipient) Price by Application
    • 5.3.1 Global Albumin (as Excipient) Price by Application (2016-2021)
    • 5.3.2 Global Albumin (as Excipient) Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Albumin (as Excipient) Market Size by Type
    • 6.1.1 North America Albumin (as Excipient) Sales by Type (2016-2027)
    • 6.1.2 North America Albumin (as Excipient) Revenue by Type (2016-2027)
  • 6.2 North America Albumin (as Excipient) Market Size by Application
    • 6.2.1 North America Albumin (as Excipient) Sales by Application (2016-2027)
    • 6.2.2 North America Albumin (as Excipient) Revenue by Application (2016-2027)
  • 6.3 North America Albumin (as Excipient) Market Size by Country
    • 6.3.1 North America Albumin (as Excipient) Sales by Country (2016-2027)
    • 6.3.2 North America Albumin (as Excipient) Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Albumin (as Excipient) Market Size by Type
    • 7.1.1 Europe Albumin (as Excipient) Sales by Type (2017-2027)
    • 7.1.2 Europe Albumin (as Excipient) Revenue by Type (2017-2027)
  • 7.2 Europe Albumin (as Excipient) Market Size by Application
    • 7.2.1 Europe Albumin (as Excipient) Sales by Application (2017-2027)
    • 7.2.2 Europe Albumin (as Excipient) Revenue by Application (2017-2027)
  • 7.3 Europe Albumin (as Excipient) Market Size by Country
    • 7.3.1 Europe Albumin (as Excipient) Sales by Country (2017-2027)
    • 7.3.2 Europe Albumin (as Excipient) Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Albumin (as Excipient) Market Size by Type
    • 8.1.1 Asia Pacific Albumin (as Excipient) Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Albumin (as Excipient) Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Albumin (as Excipient) Market Size by Application
    • 8.2.1 Asia Pacific Albumin (as Excipient) Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Albumin (as Excipient) Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Albumin (as Excipient) Market Size by Region
    • 8.3.1 Asia Pacific Albumin (as Excipient) Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Albumin (as Excipient) Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Albumin (as Excipient) Market Size by Type
    • 9.1.1 Latin America Albumin (as Excipient) Sales by Type (2019-2027)
    • 9.1.2 Latin America Albumin (as Excipient) Revenue by Type (2019-2027)
  • 9.2 Latin America Albumin (as Excipient) Market Size by Application
    • 9.2.1 Latin America Albumin (as Excipient) Sales by Application (2019-2027)
    • 9.2.2 Latin America Albumin (as Excipient) Revenue by Application (2019-2027)
  • 9.3 Latin America Albumin (as Excipient) Market Size by Country
    • 9.3.1 Latin America Albumin (as Excipient) Sales by Country (2019-2027)
    • 9.3.2 Latin America Albumin (as Excipient) Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Albumin (as Excipient) Market Size by Type
    • 6.1.1 Middle East and Africa Albumin (as Excipient) Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Albumin (as Excipient) Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Albumin (as Excipient) Market Size by Application
    • 6.2.1 Middle East and Africa Albumin (as Excipient) Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Albumin (as Excipient) Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Albumin (as Excipient) Market Size by Country
    • 6.3.1 Middle East and Africa Albumin (as Excipient) Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Albumin (as Excipient) Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 CSL
    • 11.1.1 CSL Corporation Information
    • 11.1.2 CSL Overview
    • 11.1.3 CSL Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 CSL Albumin (as Excipient) Product Description
    • 11.1.5 CSL Related Developments
  • 11.2 Grifols
    • 11.2.1 Grifols Corporation Information
    • 11.2.2 Grifols Overview
    • 11.2.3 Grifols Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Grifols Albumin (as Excipient) Product Description
    • 11.2.5 Grifols Related Developments
  • 11.3 Takeda
    • 11.3.1 Takeda Corporation Information
    • 11.3.2 Takeda Overview
    • 11.3.3 Takeda Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Takeda Albumin (as Excipient) Product Description
    • 11.3.5 Takeda Related Developments
  • 11.4 Octapharma
    • 11.4.1 Octapharma Corporation Information
    • 11.4.2 Octapharma Overview
    • 11.4.3 Octapharma Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Octapharma Albumin (as Excipient) Product Description
    • 11.4.5 Octapharma Related Developments
  • 11.5 Hualan Bio
    • 11.5.1 Hualan Bio Corporation Information
    • 11.5.2 Hualan Bio Overview
    • 11.5.3 Hualan Bio Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Hualan Bio Albumin (as Excipient) Product Description
    • 11.5.5 Hualan Bio Related Developments
  • 11.6 CBPO
    • 11.6.1 CBPO Corporation Information
    • 11.6.2 CBPO Overview
    • 11.6.3 CBPO Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 CBPO Albumin (as Excipient) Product Description
    • 11.6.5 CBPO Related Developments
  • 11.7 Shanghai RAAS
    • 11.7.1 Shanghai RAAS Corporation Information
    • 11.7.2 Shanghai RAAS Overview
    • 11.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Shanghai RAAS Albumin (as Excipient) Product Description
    • 11.7.5 Shanghai RAAS Related Developments
  • 11.8 Kedrion
    • 11.8.1 Kedrion Corporation Information
    • 11.8.2 Kedrion Overview
    • 11.8.3 Kedrion Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Kedrion Albumin (as Excipient) Product Description
    • 11.8.5 Kedrion Related Developments
  • 11.9 LFB Group
    • 11.9.1 LFB Group Corporation Information
    • 11.9.2 LFB Group Overview
    • 11.9.3 LFB Group Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 LFB Group Albumin (as Excipient) Product Description
    • 11.9.5 LFB Group Related Developments
  • 11.10 Albumedix
    • 11.10.1 Albumedix Corporation Information
    • 11.10.2 Albumedix Overview
    • 11.10.3 Albumedix Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Albumedix Albumin (as Excipient) Product Description
    • 11.10.5 Albumedix Related Developments
  • 11.1 CSL
    • 11.1.1 CSL Corporation Information
    • 11.1.2 CSL Overview
    • 11.1.3 CSL Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 CSL Albumin (as Excipient) Product Description
    • 11.1.5 CSL Related Developments
  • 11.12 Merck
    • 11.12.1 Merck Corporation Information
    • 11.12.2 Merck Overview
    • 11.12.3 Merck Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Merck Product Description
    • 11.12.5 Merck Related Developments
  • 11.13 Ventria (InVitria)
    • 11.13.1 Ventria (InVitria) Corporation Information
    • 11.13.2 Ventria (InVitria) Overview
    • 11.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.13.4 Ventria (InVitria) Product Description
    • 11.13.5 Ventria (InVitria) Related Developments
  • 11.14 HiMedia
    • 11.14.1 HiMedia Corporation Information
    • 11.14.2 HiMedia Overview
    • 11.14.3 HiMedia Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.14.4 HiMedia Product Description
    • 11.14.5 HiMedia Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Albumin (as Excipient) Value Chain Analysis
  • 12.2 Albumin (as Excipient) Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Albumin (as Excipient) Production Mode & Process
  • 12.4 Albumin (as Excipient) Sales and Marketing
    • 12.4.1 Albumin (as Excipient) Sales Channels
    • 12.4.2 Albumin (as Excipient) Distributors
  • 12.5 Albumin (as Excipient) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Albumin (as Excipient) Industry Trends
  • 13.2 Albumin (as Excipient) Market Drivers
  • 13.3 Albumin (as Excipient) Market Challenges
  • 13.4 Albumin (as Excipient) Market Restraints

14 Key Findings in The Global Albumin (as Excipient) Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Albumin (as Excipient) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Albumin (as Excipient) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Human Serum Albumin
    Recombinant Albumin
    In terms of type, Human Serum Albumin has the highest proportion of revenue, exceeding 98% in 2019.

    Segment by Application
    Cell Culture Media
    Medical Supplements
    Therapeutics
    Therapeutics had the highest share of sales by application, at 73.27% in 2019.

    By Company
    CSL
    Grifols
    Takeda
    Octapharma
    Hualan Bio
    CBPO
    Shanghai RAAS
    Kedrion
    LFB Group
    Albumedix
    Biotest
    Merck
    Ventria (InVitria)
    HiMedia

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now